Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish
No Result
View All Result
FuturoProssimo
Monday, April 19, 2021
  • Tech
  • Medicine
  • Society
  • Ambience
  • Spazio
  • Transportation
  • concepts
  • H+
Contact
FuturoProssimo
No Result
View All Result

Read in:
Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

February 21 2020

A urine test can detect bladder cancer 10 years earlier

Gianluca Ricciodi Gianluca Riccio
in Medicine
Send to FacebookPin on PinterestSend on TwitterSend on Whatsappon Linkedin
A urine test can detect bladder cancer 10 years earlier

A massive cohort study confirmed an important role that a biomarker has in detecting bladder cancer early. Off to further studies.

A compelling new study from the WHO's International Agency for Research on Cancer (IARC) suggests that a simple biomarker in urine could be an effective predictive test for bladder cancer, signaling the presence of the disease up to 10 years before it appears. clinical signs.

Bladder cancer is a type of cancer that needs to be caught in its early stages. The best diagnostic technique currently available is an invasive imaging procedure called cystoscopy.

There are currently several biomarkers to be detected in the urine being studied, but none have been clinically verified enough to be widely recommended. And even in that case they are effective tools only in the control of active cases and in detecting the first signs of the disease.

Maybe you are also interested

Glioblastoma, breakthrough in the treatment of this dangerous brain cancer

New health technology detects vital signs from the face in a video

First human tests of the brain cancer vaccine completed

Goodbye colonoscopy: there is Pillcam, the video camera in pills to swallow

Bladder cancer, the role of genetics

For several years, researchers have known that mutations in the reverse telomerase transcriptase (TERT) gene are incredibly common in many cases of bladder cancer. These TERT mutations can be detected in urine samples, but until now it was unclear whether this biomarker was an effective early detection tool.

The study on TERT mutations

To investigate this possibility, IARC scientists collaborated with a team of Iranian researchers working on a long-term research project called Cohort study Golestan.

Not always the potential benefits against cancer they are accidentally found. Rather. In this case the planning was painstaking.

The project, which started in 2004, recruited over 50.000 healthy subjects for a long-term study. At the beginning of the project, a bank of biological samples was created: blood, urine, hair and nails. This provided the researchers with a valuable basis for study.

“We collected urine samples from 50.045 Iranian individuals and followed up with a follow-up of over 10 years. This research is one of the few population-based research that offers the opportunity to evaluate urinary biomarkers for the clinical detection of bladder cancer ”. He explains it Reza Malekzaded, coauthor and principal responsible for the Golestan cohort study.

Bladder cancer, the co-author of the Golestan cohort study
Reza Malekzaded

In the end, 38 people developed bladder cancer from the study group and TERT mutations were detected in 46,7% of these subjects. Perhaps more importantly, no TERT mutations were detected in a control group of 152 subjects without cancer.

“Our results provide the first evidence on the potential for TERT promoter mutations. It is a promising non-invasive biomarker for the early diagnosis of bladder cancer ", says Ismail Hosen, another author of the study.

As always, I recommend caution

The researchers admit that this is an initial pilot study. The cohort of subjects with bladder cancer is still small, 38 people are not many. Therefore, the predictive nature of TERT mutations will still need to be verified before approaching clinical use.

However, this is an extraordinarily promising test, simple and cheap for bladder cancer. If validated in larger studies, it could offer doctors a valuable new tool to catch this tumor in its early stages.

The new research was published in the EbioMedicine magazine.

tags: biomarkerscancerBladder cancerdiagnosesUrine
Previous post

Circadian light: the science of light that influences sleep, mood and actions

Next article

Coronavirus also spreads from the stool. Explained the infections on ships

Collaborate!

We are open to visions about the future. Submit an article, disclose the results of a search or scientific discoveries, shows points of view on a theme, tells about a change.

Contact us

Most read of the week

  • US intelligence analyzes the future, and it doesn't look good at all

    US intelligence analyzes the future, and it doesn't look good at all

    119 shares
    Share 47 Tweet 30
  • Plants that “exude” metal: can agromining replace mines?

    70 shares
    Share 28 Tweet 17
  • The rising of the sea is unstoppable. You need to think big

    51 shares
    Share 20 Tweet 13
  • Physicists at Microsoft think the universe is a self-taught computer

    78 shares
    Share 31 Tweet 19
The last
Advice

5 drugs that will prolong your youth, and help you save a lot of money

Society

Digital Nomads: Their rise tells us a lot about the future of remote working

Spazio

Ingenuity flies to Mars: 40 seconds that will make history

concepts

Airo, electric car that "sucks" the pollution of other cars: launch in 2023

archive

Next article
coronavirus stool

Coronavirus also spreads from the stool. Explained the infections on ships

Facebook

Instagram

Telegram

Twitter

Clubhouse

Near future

Futuroprossimo.it is an Italian futurology resource open since 2006: every day news about the near future. Scientific discoveries, medical research, prototypes, concepts and predictions about the future for free.

Tag

Ambience Architecture Club Communication concepts Advice Economy Energy Events Gadgets The future of yesterday The newspaper of tomorrow Italy Next Medicine Military Weather Robotica Society Spazio Technology transhumanism Transportation Video

The author

Gianluca Riccio, copywriter and journalist - Born in 1975, he is the creative director of an advertising agency, he is affiliated with the Italian Institute for the Future, World Future Society and H +, Network of Italian Transhumanists.

Home / Author / IDEA / archive / Promo on FP

Collaborate! Are you interested in writing a post on Futuroprossimo? Click here for contacts.

Categories

Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.
© 2021 Futuroprossimo

  • Home
  • Contact
  • archive
  • Technology
  • Medicine
  • Transportation
  • Weather
  • Society
  • Ambience
  • transhumanism

© 2021 Futuroprossimo - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

This site uses cookies. By continuing to read it, you consent to their use.